Clinical Trial Update: Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Lopinavir/Ritonavir tablets vs soft gel capsules and once-daily vs twice-daily dosing, coadministered with NRTIs, in antiretroviral-naiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Lopinavir/ritonavir soft gel capsules (lopinavir/ritonavir)
• Lopinavir/ritonavir tablets (lopinavir/ritonavir)

Snippet

Sponsor: Abbott | Conditions: Human Immunodeficiency Virus Infections | Phase 3 | Status: COMPLETED | Results posted: 2009-08-20